{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:39:07Z","timestamp":1790753947315,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medicen"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijpharm.2018.01.021","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T01:42:30Z","timestamp":1516153350000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study"],"prefix":"10.1016","volume":"538","author":[{"given":"V.","family":"Busignies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mollereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bourry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rosa-Calatrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tchoreloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.01.021_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-008-9559-6","article-title":"Development of stable influenza vaccine powder formulations: challenges and possibilities","author":"Amorij","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0010","series-title":"Mucoadhesive Buccal Tablets for the Treatment of Orofacial Herpes","author":"Attali","year":"2012"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0015","first-page":"41","article-title":"Excipients used in lyophilization of small molecules","volume":"1","author":"Baheti","year":"2010","journal-title":"J. Excipients Food Chem."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0020","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1128\/IAI.67.8.4276-4279.1999","article-title":"Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization","volume":"67","author":"Barackman","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0025","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy: a meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ejps.2012.08.014","article-title":"Effect of protein release rates from tablet formulations on the immune response after sublingual immunization","volume":"47","author":"Borde","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.07.011","article-title":"Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell\/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea","volume":"108","author":"Borde","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0045","doi-asserted-by":"crossref","first-page":"e9068","DOI":"10.1371\/journal.pone.0009068","article-title":"Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs","volume":"5","author":"Brookes","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0050","doi-asserted-by":"crossref","DOI":"10.1051\/vetres\/2010046","article-title":"Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus","volume":"41","author":"Busquets","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","author":"Cox","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0075","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"\u00c7uburu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0080","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1099\/jgv.0.000573","article-title":"Mycoplasma hyopneumoniae does not affect the interferon-related anti-viral response but predisposes the pig to a higher level of inflammation following swine influenza virus infection","volume":"97","author":"Deblanc","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/14787210.2014.880337","article-title":"Acyclovir Lauriad(\u00ae): a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis","volume":"12","author":"Downing","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0090","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/nprot.2014.180","article-title":"Influenza A virus isolation, culture and identification","volume":"9","author":"Eisfeld","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0095","series-title":"2.9.7. Friability of Uncoated Tablets","author":"European Pharmacopeia","year":"2017"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jps.2600590523","article-title":"Determination of tablet strength by the diametral-compression test","volume":"59","author":"Fell","year":"1970","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/erv.12.81","article-title":"Optimizing efficacy of mucosal vaccines","volume":"11","author":"Gebril","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022172400022610","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J. Hyg. (Lond.)"},{"key":"10.1016\/j.ijpharm.2018.01.021_b9000","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0115","unstructured":"Kendal, A., Pereira, M., Skehel, J., 1982. Concepts and Procedures for Laboratory Based Influenza Surveillance. Washington DC"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0120","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2014.05.060","article-title":"Buccal and sublingual vaccine delivery","volume":"190","author":"Kraan","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2018.01.021_b9005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2010.12.014","article-title":"Sublingual mucosa: A new vaccination route for systemic and mucosal immunity","author":"Kweon","year":"2011","journal-title":"Cytokine."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0125","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1099\/vir.0.014480-0","article-title":"Pathogenesis and transmission of the novel swine-origin influenza virus A\/H1N1 after experimental infection of pigs","volume":"90","author":"Lange","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(15)00266-2","article-title":"High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial","volume":"15","author":"Liebowitz","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0135","first-page":"405","article-title":"Bilan l\u00e9sionnel des poumons de porcs charcutiers \u00e0 l\u2019abattoir","volume":"14","author":"Madec","year":"1982","journal-title":"J. Rech. Porc. en Fr."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079041","article-title":"Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35\u00ae in compliance with current regulations","volume":"8","author":"Muller","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejpb.2014.07.014","article-title":"Study of the Lactobacillus rhamnosus Lcr35\u00ae properties after compression and proposition of a model to predict tablet stability","volume":"88","author":"Muller","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0150","first-page":"107","article-title":"The systemic and mucosal immune response of humans to influenza A virus","volume":"146","author":"Murphy","year":"1989","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1208\/s12248-014-9565-z","article-title":"Simplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine","volume":"16","author":"Murugappan","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0160","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JCM.27.12.2666-2671.1989","article-title":"Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines","volume":"27","author":"Powers","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0165","doi-asserted-by":"crossref","unstructured":"R Development Core Team, 2016. R: A Language and Environment for Statistical Computing. R Found. Stat. Comput. Vienna Austria 0, {ISBN} 3-900051-07-0. http:\/\/doi.org\/10.1038\/sj.hdy.6800737.","DOI":"10.1038\/sj.hdy.6800737"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ilar\/ilv002","article-title":"Swine as a model for influenza A virus infection and immunity","volume":"56","author":"Rajao","year":"2015","journal-title":"ILAR J."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0975-7406.76478","article-title":"Mucoadhesive drug delivery systems","volume":"3","author":"Shaikh","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.ijpharm.2018.01.021_b9010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4110\/in.2013.13.3.81","article-title":"Sublingual delivery of vaccines for the induction of mucosal immunity","volume":"13","author":"Shim","year":"2013","journal-title":"Immune Netw."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860701637966","article-title":"Rational design of nasal vaccines","volume":"16","author":"Sl\u00fctter","year":"2008","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.01.021_b9015","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.0708684105","article-title":"Sublingual vaccination with influenza virus protects mice against lethal viral infection","volume":"105","author":"Song","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0190","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11095-009-9861-y","article-title":"The impact of dose and solubility of additives on the release from HPMC matrix tablets-identifying critical conditions","volume":"26","author":"Tajarobi","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0195","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/14760584.2016.1182869","article-title":"Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination","volume":"15","author":"Tomar","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jamp.2011.0931","article-title":"Pulmonary vaccine delivery: a realistic approach?","volume":"25","author":"Tonnis","year":"2012","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0210","series-title":"Disease of Swine","first-page":"557","article-title":"Influenza virus","author":"Van Reeth","year":"2012"},{"key":"10.1016\/j.ijpharm.2018.01.021_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","author":"Wang","year":"2000","journal-title":"J. Pharm. Int."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0220","first-page":"93","article-title":"Recommended composition of influenza virus vaccines for use in the 2014\u20132015 northern hemisphere influenza season Wkly","volume":"89","author":"Who","year":"2014","journal-title":"Epidemiol. Rec."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.ijpharm.2018.01.021_b0230","article-title":"Manual of diagnostic tests and vaccines for terrestrial animals","volume":"1\u201325","author":"World Organisation for Animal Health, Cossio","year":"2015","journal-title":"Oie"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318300346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318300346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T18:23:06Z","timestamp":1603650186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318300346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0378517318300346"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.021","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}